Deciphering the role of <i>ELAVL1</i>: Insights from pan-cancer multiomics analyses with emphasis on nasopharyngeal carcinoma

Abstract

In summary, <i>ELAVL1</i> exhibits diverse and complex involvement in tumor progression. Targeting it might inhibit tumor progression, making it a promising biomarker and therapeutic target for enhancing cancer treatment outcomes.